National Jewish Health is a Denver, Colorado academic hospital/clinic doing research and treatment in respiratory, cardiac, immune and related disorders. It is an internationally respected medical center that draws people from many countries to receive care.

There are 46 beds in National Jewish Health-Main Campus.

During the past decade, National Jewish Health-Main Campus conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 15 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 15 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Jewish Health-Main Campus" #1 sponsor was "National Cancer Institute (NCI)" with 40 trials, followed by "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "SWOG Cancer Research Network" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored and "NRG Oncology" with 9 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Jewish Health-Main Campus" #1 collaborator was "National Cancer Institute (NCI)" with 40 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "National Jewish Health-Main Campus" are "Stage IV Lung Cancer AJCC v8" (6 trials), "Invasive Breast Carcinoma" (5 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials), "Breast Carcinoma" (4 trials) and "Chronic Lymphocytic Leukemia" (4 trials). Many other conditions were trialed in "National Jewish Health-Main Campus" in a lesser frequency.

Most popular intervention types in "National Jewish Health-Main Campus" are "Drug" (57 trials), "Other" (56 trials), "Biological" (39 trials), "Procedure" (32 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (24 trials), "Quality-of-Life Assessment" (24 trials), "Biospecimen Collection" (19 trials), "Questionnaire Administration" (18 trials) and "Computed Tomography" (17 trials). Other intervention names were less common.

The vast majority of trials in "National Jewish Health-Main Campus" are 70 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "National Jewish Health-Main Campus". undefined are not yet recruiting, 22 are recruiting, 44 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in National Jewish Health-Main Campus, 4 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Jewish Health-Main Campus, 1 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".